Pillier-Loriette C, Wingerter P, Gerota J, Schenmetzler C, Reviron J, Aymard P
Rev Fr Transfus Immunohematol. 1983 Jun;26(3):299-312. doi: 10.1016/s0338-4535(83)80033-6.
The maximum level of plasma hemoglobin in standard fresh frozen plasma before freezing has been mixed at 50 mg/l by french regulations. As no reference method is specified by the standards, we have adapted a technique where pseudo-peroxydasic activity of the hemoglobin is revealed by 3,3'-5,5', tetramethylbenzidine, a non carcinogenic chromogen derivate from benzidine. A 4 points reference scale is plotted for each plasma to be tested, thus reducing eventual interferences between pseudo-peroxydasic activity of the hemoglobin and other plasma proteins. We compared our modified technique to other existing ones: Vanzetti's extraction technique [8] whose main drawbacks are the use of flammable solvents and carcinogenic chromogen. Standefer's technique [10] involving plasma preincubation in H2O2 solution, which reveals protein interferences but is imprecise as it relies on only one reference point and does not show whether chromogen saturation is present. The level fixed by regulations is higher than the mean level indicated by our method, based on 118 samples of fresh plasma obtained by double centrifugation of whole blood collected on CPD as anticoagulant. It is also higher than the level indicated by the same method for plasma samples drawn from continuous or discontinuous flow cytapheresis (IBM 2997; Haemonetics V 50) using ACD - A or ACD - AA 16 as anticoagulant. Our method measures with precision low levels in plasma. Furthermore it is cheap, simple and easy to run in a blood transfusion center.
根据法国法规,标准新鲜冰冻血浆在冷冻前的血浆血红蛋白最高水平混合后为50毫克/升。由于标准中未指定参考方法,我们采用了一种技术,其中血红蛋白的假过氧化物酶活性通过3,3'-5,5'-四甲基联苯胺来显示,3,3'-5,5'-四甲基联苯胺是一种源自联苯胺的非致癌显色剂。为每个待测血浆绘制一个4点参考量表,从而减少血红蛋白的假过氧化物酶活性与其他血浆蛋白之间的潜在干扰。我们将我们改进的技术与其他现有技术进行了比较:万泽蒂的提取技术[8],其主要缺点是使用易燃溶剂和致癌显色剂。斯坦德费尔的技术[10]涉及在过氧化氢溶液中对血浆进行预孵育,该技术揭示了蛋白质干扰,但不准确,因为它仅依赖于一个参考点,并且没有显示是否存在显色剂饱和。法规规定的水平高于我们基于118份通过对以CPD作为抗凝剂采集的全血进行两次离心获得的新鲜血浆样本的方法所指示的平均水平。它也高于使用ACD - A或ACD - AA 16作为抗凝剂从连续或非连续流式细胞分离术(IBM 2997;Haemonetics V 50)采集的血浆样本的相同方法所指示的水平。我们的方法能够精确测量血浆中的低水平。此外,它成本低廉、操作简单,易于在输血中心开展。